CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma

Liu,Wen‑Hui; Li,Xin; Zhu,Xin‑Ling; Hou,Mei‑Ling; Zhao,Wei

doi:10.3892/ol.2018.8499

CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma

Authors:
- Wen‑Hui Liu
- Xin Li
- Xin‑Ling Zhu
- Mei‑Ling Hou
- Wei Zhao
View Affiliations

Affiliations: School of Basic Medical Sciences, Jinzhou Medical University, Jinzhou, Liaoning 121200, P.R. China, Department of Prosthodontics, Second Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121200, P.R. China, Department of Periodontology, Beijing Stomatological Hospital Capital Medical University, Beijing 100050, P.R. China
Published online on: April 16, 2018 https://doi.org/10.3892/ol.2018.8499
Pages: 9033-9042
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study evaluated the expression and potential role of CD63 in the migration and invasion of tongue squamous cell carcinoma (TSCC) cells. Immunohistochemistry (IHC) was used to investigate the association between the expression level of CD63 protein and the histological differentiation of samples from 40 patients with TSCC and four normal tongue tissue specimens. RNA interference (RNAi) and gene transfection technology were used to alter the expression of CD63 in TCA8113 cells. The stable silencing and overexpression of CD63 in the TCA8113 cell line was used to assess the impact of the CD63 expression level on the migratory and invasive abilities of TCA8113 cells in a wound healing assay and a Transwell invasion assay. The effect of CD63 on the expression of matrix metalloproteinase (MMP)‑2 and ‑9 were evaluated by western blot analysis. The results of IHC revealed a positive association between the CD63 expression level and the histopathological differentiation of TSCC and a negative association between the CD63 expression level and lymph node metastasis in TSCC. Western blotting revealed that the expressions of MMP‑2 and MMP‑9 were clearly upregulated in CD63‑silenced TCA8113 cells but reduced in CD63‑overexpressing TCA8113 cells, compared with the control. The wound‑healing speed and the number of cells invading Matrigel‑coated filters were negatively associated with the CD63 expression level. In summary, the results of the present study revealed that CD63 may be an inhibitor of TSCC malignancy and lymph node metastasis and may have applications in the prediction of prognosis and gene therapy for patients of TSCC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
3	Sano D and Myers JN: Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
4	Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin. 52:195–215. 2002. View Article : Google Scholar : PubMed/NCBI
5	Ren W, Lian P, Cheng L, Du P, Guan X, Wang H, Ding L, Gao Z, Huang X, Xiao F, et al: FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest. Mol Med Rep. 12:3958–3964. 2015. View Article : Google Scholar : PubMed/NCBI
6	Liu Z, He Q, Ding X, Zhao T, Zhao L and Wang A: SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells. Int J Biochem Cell Biol. 60:139–146. 2015. View Article : Google Scholar : PubMed/NCBI
7	Jia LF, Gan YH and Yu GY: Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior. Beijing Da Xue Xue Bao Yi Xue Ban. 48:5–9. 2016.(In Chinese). PubMed/NCBI
8	Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM and Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res. 48:2955–2962. 1988.PubMed/NCBI
9	Maecker HT, Todd SC and Levy S: The tetraspanin superfamily: Molecular facilitators. FASEB J. 11:428–442. 1997. View Article : Google Scholar : PubMed/NCBI
10	Pols MS and Klumperman J: Trafficking and function of the tetraspaninCD63. Exp Cell Res. 315:1584–1592. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kobayashi T, Vischer UM, Rosnoblet C, Lebrand C, Lindsay M, Parton RG, Kruithof EK and Gruenberg J: The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell. 11:1829–1843. 2000. View Article : Google Scholar : PubMed/NCBI
12	Kang M, Ryu J, Lee D, Lee MS, Kim HJ, Nam SH, Song HE, Choi J, Lee GH, Kim TY, et al: Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities. PLoS One. 9:e1028172014. View Article : Google Scholar : PubMed/NCBI
13	Hunziker W and Geuze HJ: Intracellular trafficking of lysosomal membrane proteins. Bioessays. 18:379–389. 1996. View Article : Google Scholar : PubMed/NCBI
14	Atkinson B, Ernst CS, Ghrist BF, Herlyn M, Blaszczyk M, Ross AH, Herlyn D, Steplewski Z and Koprowski H: Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res. 44:2577–2581. 1984.PubMed/NCBI
15	Jang HI and Lee H: A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med. 35:317–323. 2003. View Article : Google Scholar : PubMed/NCBI
16	Radford KJ, Thorne RF and Hersey P: Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol. 158:3353–3358. 1997.PubMed/NCBI
17	Kwon MS, Shin SH, Yim SH, Lee KY, Kang HM, Kim TM and Chung YJ: CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Lung Cancer. 57:46–53. 2007. View Article : Google Scholar : PubMed/NCBI
18	Sauer G, Kurzeder C, Grundmann R, Kreienberg R, Zeillinger R and Deissler H: Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Oncol Rep. 10:405–410. 2003.PubMed/NCBI
19	Sordat I, Decraene C, Silvestre T, Petermann O, Auffray C, Piétu G and Sordat B: Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells. Lab Invest. 82:1715–1724. 2002. View Article : Google Scholar : PubMed/NCBI
20	Shear M: The aggressive nature of the odontogenic keratocyst: Is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. Oral Oncol. 38:407–415. 2002. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Woegerbauer M, Thurnher D, Houben R, Pammer J, Kloimstein P, Heiduschka G, Petzelbauer P and Erovic BM: Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: Strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod Pathol. 23:751–762. 2010. View Article : Google Scholar : PubMed/NCBI
23	Chen Z, Gu S, Trojanowicz B, Liu N, Zhu G, Dralle H and Hoang-Vu C: Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma. World J Surg Oncol. 9:432011. View Article : Google Scholar : PubMed/NCBI
24	Fellmann C and Lowe SW: Stable RNA interference rules for silencing. Nat Cell Biol. 16:10–18. 2014. View Article : Google Scholar : PubMed/NCBI
25	Stepanenko AA and Dmitrenko VV: HEK293 in cell biology and cancer research: Phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene. 569:182–190. 2015. View Article : Google Scholar : PubMed/NCBI
26	Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol. 18:1135–1149. 2000. View Article : Google Scholar : PubMed/NCBI
27	Yurchenco PD and Schittny JC: Molecular architecture of basement membranes. FASEB J. 4:1577–1590. 1990. View Article : Google Scholar : PubMed/NCBI
28	Barsky SH, Siegal GP, Jannotta F and Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest. 49:140–147. 1983.PubMed/NCBI
29	Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284:67–68. 1980. View Article : Google Scholar : PubMed/NCBI
30	Kusukawa J, Sasaguri Y, Shima I, Kameyama T and Morimatsu M: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol. 99:18–23. 1993. View Article : Google Scholar : PubMed/NCBI
31	Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro KI, Hino S, Omotehara F, Yoshida H and Sato M: Active-MMP2 in cancer cell nests of oral cancer patients: Correlation with lymph node metastasis. Int J Oncol. 13:699–704. 1998.PubMed/NCBI
32	Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S, Nakamura S and Shirasuna K: Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis. 17:315–323. 1999. View Article : Google Scholar : PubMed/NCBI
33	Hong SD, Hong SP, Lee JI and Lim CY: Expression of matrix metalloproteinase-2 and −9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol. 36:207–213. 2000. View Article : Google Scholar : PubMed/NCBI
34	Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP and Graner E: Matrix metalloproteinase-2 and −9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol. 20:189–194. 2002.PubMed/NCBI